FDA Pushes Back Enforcement Deadline for MoCRA Facility Registration and Product Listing Requirements
Duane Morris Life Sciences Law
by Duane Morris
3w ago
Today, FDA announced updated guidance regarding its MoCRA rollout. FDA  does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing for an additional six months after the December 29, 2023, statutory deadline, or until July 1, 2024, to provide regulated industry additional time to comply with these requirements. To read the full text ..read more
Visit website
Federal Trade Commission Issues Notice Letters Regarding Allegedly Improper Orange Book Listings
Duane Morris Life Sciences Law
by Sarah O'Laughlin Kulik
1M ago
On November 7, 2023, the Federal Trade Commission (“FTC”) announced that it had issued notice letters to 10 life sciences companies regarding 100 patents that the FTC contends are improperly listed in the Orange Book, the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations. The announcement comes of the heels of the FTC’s policy statement ..read more
Visit website
Boston Partner Daniel Pierce Interviews Treventis CEO Chris Barden
Duane Morris Life Sciences Law
by Duane Morris
1M ago
Daniel R. Pierce, Corporate and IP partner in the Boston office, recently spoke with Chris Barden, CEO of firm client Treventis, about his background, his company’s research into misfolded proteins to develop cures for central nervous system diseases like Alzheimer’s, as well as Chris’ thoughts and experience at the BIO Conference. Can you tell us ..read more
Visit website
MoCRA featured on the Class Action Weekly Wire Podcast with Guest Kelly Bonner
Duane Morris Life Sciences Law
by Duane Morris
1M ago
In Episode 35 of the  Class Action Weekly Wire podcast,  host Jerry Maatman interviews Duane Morris associate Kelly Bonner about the Modernization of Cosmetics  Regulation Act (MoCRA). Watch the episode below ..read more
Visit website
Rick Ball and Coleen Hill to Speak at MassMEDIC Regulatory Roundup
Duane Morris Life Sciences Law
by Duane Morris
1M ago
Duane Morris attorneys Rick Ball and Coleen Hill will be speakers at MassMEDIC’s Regulatory Roundup, to be held on November 15, 2023 from 8:00 a.m. to 4:15 p.m.  Rick and Coleen will present “When Things Go Wrong: Navigating Enforcement When the FDA, SEC, and DOJ Are All Involved.” For more information and to register for ..read more
Visit website
Federal Regulatory Laws Due Overhaul after MoCRA
Duane Morris Life Sciences Law
by Duane Morris
2M ago
On December 23, 2022, Congress enacted the Modernization of Cosmetics Regulation Act (MoCRA)—the first major statutory change to the U.S. federal government’s ability to regulate cosmetics since 1938. Passed with bipartisan and industry support, MoCRA expands the Food and Drug Administration’s authority over cosmetics, and creates substantial new obligations for manufacturers, packers and distributors of ..read more
Visit website
FDA Proposes Updates to 510(k) Path
Duane Morris Life Sciences Law
by Will Heaston
2M ago
On September 6, 2023, the FDA released three draft guidance documents that seek to “modernize” the 510(k) premarket notification process.  Ever since the FDA first proposed “transformative new steps” to the program in 2018, the agency has promised to further update the 510(k) clearance pathway in an effort to better balance technological innovation and patient safety.  In ..read more
Visit website
FTC Targets Private Equity in Challenge to Anesthesiology Roll-Ups
Duane Morris Life Sciences Law
by Duane Morris
2M ago
On September 21, 2023, the Federal Trade Commission sued U.S. Anesthesia Partners Inc. and Welsh, Carson, Anderson & Stowe XI L.P., among other private equity funds, in the United States District Court for the Southern District of Texas under the antitrust laws. Specifically, FTC alleges that the defendants engaged in an anti-competitive scheme to consolidate ..read more
Visit website
FTC Issues Policy Statement Cautioning Branded Drug Companies Against Improper Orange Book Listings
Duane Morris Life Sciences Law
by Sean P. McConnell
2M ago
Duane Morris Takeaways: On Thursday September 14, 2023, the FTC issued a policy statement warning brand drug companies that improper listing of patents in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly referred to as the “Orange Book” could violate Section 5 of the FTC Act. The Hatch-Waxman Act and FDA regulations outline ..read more
Visit website
FDA’s New Electronic Portal for Facility Registration and Product Listing of Cosmetic Product Facilities and Products Under MoCRA
Duane Morris Life Sciences Law
by Duane Morris
2M ago
Continuing its implementation of the Modernization of Cosmetics Regulation Act’s (MoCRA), and following on the heels of FDA’s Draft Guidance on Facility Registration and Product Listing (previously discussed here), on September 15, 2023, FDA announced its newly developed draft electronic submission portal, Cosmetics Direct, to assist persons submitting cosmetic product facility registrations and product listings under newly added ..read more
Visit website

Follow Duane Morris Life Sciences Law on FeedSpot

Continue with Google
Continue with Apple
OR